Bluebird Bio Inc (BLUE)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

60 BINNEY STREET CAMBRIDGE, MA 02142

Bluebird Bio, Inc., a clinical-stage biotechnology company, focuses on the development, manufacture, and marketing of therapies to treat various human diseases.

Data based on most recent fiscal year report
Market Cap5.302 Billion Shares Outstanding55.33 Million Avg Volume979.957 Thousand
1-Yr BETA vs S&P TR1.648 Current Ratio9.69 Quick Ratio9.69

Are you looking for these stocks instead?

View SEC Filings from BLUE instead.

View recent insider trading info

Funds Holding BLUE (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BLUE BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

25 Thousand total shares from 13 transactions

Exercise Derivative Conversion (M)

2.4 Thousand total shares from 2 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

GILLIS STEVEN

  • Director
0 2020-01-22 0

GREGORY PHILIP D CHIEF SCIENTIFIC OFFICER

24,708 2020-01-10 17

DAVIDSON DAVID CHIEF MEDICAL OFFICER

28,319 2020-01-07 10

LESCHLY NICK PRESIDENT AND CEO

225,411 2020-01-07 2

COLE JASON CHIEF OPERATING AND

  • LEGAL OFFICER
25,049 2020-01-07 4

WENTWORTH KORY JAMES PRINCIPAL ACCOUNTING OFFICER

6,308 2020-01-07 8

FINGER ALISON CECILY CHIEF COMMERCIAL OFFICER

18,148 2020-01-07 3

SMITH-FARRELL JOANNE CHIEF BUSINESS OFFICER

11,976 2020-01-07 2

DIXON WENDY L

  • Director
12,536 2019-12-31 1

MARAGANORE JOHN CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2019-12-23 0

HEDLEY MARY LYNNE

  • Director
340 2019-11-16 0

SCHENKEIN DAVID P

  • Director
447,421 2019-11-13 1

SELLERS WILLIAM R.

  • Director
2,000 2019-09-25 2

LYNCH DANIEL

  • Director
391,277 2019-09-12 1

WALSH JEFFREY T. CHIEF STRATEGY OFFICER

  • Officer
40,921 2019-08-20 8

FINER MITCHELL H.

  • Director
0 2019-07-31 0

ARCH VENTURE FUND VII, L.P.

ARCH VENTURE PARTNERS VII, L.P.

ARCH VENTURE PARTNERS VII, LLC

CRANDELL KEITH

BYBEE CLINTON

NELSEN ROBERT

  • 10% Owner
4,242,051 2019-07-15 0

TEPPER ROBERT I

  • Director
  • 10% Owner
0 2019-06-25 0

VACHON MARK

  • Director
2,000 2019-06-06 1

AGWUNOBI JOHN O

  • Director
4,700 2019-06-06 1

MELTON DOUGLAS

  • Director
4,700 2019-06-06 1

BAIRD WILLIAM D III

  • Director
0 2019-05-22 2

HIGH SUSANNA GATTI CHIEF OPERATING OFFICER

  • Officer
13,735 2018-12-06 0

MANDELL JAMES

  • Director
1,000 2018-09-10 0

SULLIVAN ERIC PRINCIPAL ACCOUNTING OFFICER

  • Officer
5,974 2017-08-03 0

DETORE JAMES M. SEE REMARKS

  • Officer
0 2016-08-04 0

BAIN LINDA CHIEF FINANCIAL OFFICER

  • Officer
41,930 2015-08-21 0

THIRD ROCK VENTURES LP

THIRD ROCK VENTURES GP, L.P.

TRV GP, LLC

  • 10% Owner
No longer subject to file 2015-04-07 0

TVM V LIFE SCIENCE VENTURES GMBH & CO KG

TVM CAPITAL GMBH

POLACK AXEL

SCHUHSLER HELMUT

GOLL ALEXANDRA

BIRNER HUBERT

FISCHER STEFAN

  • 10% Owner
2,254,357 2013-06-24 0

MULDER GEERT-JAN

  • Director
No longer subject to file 2013-06-24 0

POLACK AXEL

  • Director
2,254,357 2013-06-24 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

GREGORY PHILIP D CHIEF SCIENTIFIC OFFICER

2020-01-10 M 600 $50.51 a 25,308 24,708.00 direct

GREGORY PHILIP D CHIEF SCIENTIFIC OFFICER

2020-01-10 M 600 d 6,200 24,708.00 direct

GREGORY PHILIP D CHIEF SCIENTIFIC OFFICER

2020-01-10 S 600 $94.03 d 24,708 24,708.00 direct yes

DAVIDSON DAVID CHIEF MEDICAL OFFICER

2020-01-07 S 3,297 $89.97 d 28,319 28,319.00 direct

WENTWORTH KORY JAMES PRINCIPAL ACCOUNTING OFFICER

2020-01-07 S 223 $89.97 d 6,308 6,308.00 direct

LESCHLY NICK PRESIDENT AND CEO

2020-01-07 S 10,163 $89.97 d 56,712 225,411.00 direct

COLE JASON CHIEF OPERATING AND LEGAL OFFICER

2020-01-07 S 1,957 $89.97 d 25,049 25,049.00 direct

SMITH-FARRELL JOANNE CHIEF BUSINESS OFFICER

2020-01-07 S 408 $89.97 d 11,976 11,976.00 direct

GREGORY PHILIP D CHIEF SCIENTIFIC OFFICER

2020-01-07 S 4,134 $89.97 d 24,708 24,708.00 direct

FINGER ALISON CECILY CHIEF COMMERCIAL OFFICER

2020-01-07 S 1,049 $89.97 d 18,148 18,148.00 direct

GREGORY PHILIP D CHIEF SCIENTIFIC OFFICER

2020-01-06 S 250 $86.66 d 28,842 28,842.00 direct yes

FINGER ALISON CECILY CHIEF COMMERCIAL OFFICER

2020-01-03 S 517 $84.96 d 19,197 19,197.00 direct

WENTWORTH KORY JAMES PRINCIPAL ACCOUNTING OFFICER

2019-12-19 S 397 $92.59 d 6,449 6,449.00 direct

GREGORY PHILIP D CHIEF SCIENTIFIC OFFICER

2019-12-17 S 1,800 $94.31 d 29,092 29,092.00 direct yes

GREGORY PHILIP D CHIEF SCIENTIFIC OFFICER

2019-12-17 M 1,800 $50.51 a 30,892 29,092.00 direct

GREGORY PHILIP D CHIEF SCIENTIFIC OFFICER

2019-12-17 M 1,800 d 6,800 29,092.00 direct

GREGORY PHILIP D - Officer CHIEF SCIENTIFIC OFFICER

2019-12-05 S 250 $80.57 d 29,092 29,092.00 direct yes
Click here to report any possible errors with this stock listing.

Elevate your investments